About John Dessouki
Form D filings for Metabolics Pharma in 2024 list John Dessouki as executive officer and director.
John Dessouki first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name John Dessouki in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Dessouki works with at each company, as listed on that company's latest Form D.
Metabolics Pharma, Inc. · Form D, Sep 19, 2024
MK
Mark Kamp
Director
MF
Mark Finn
Director
BM
Barry Miller
Director
JB
Jay Brammer
Director
RL
Richard Larson
Chief Executive Officer and director